Dermatoscope Market Size will grow considerably from 2022 to 2028 owing to the rising prevalence of skin cancer. According to the American Academy of Dermatology Association, one in five Americans would develop skin cancer in their lifetime. The organization estimated around 7,180 deaths due to melanoma in 2021.
Dermatoscopy is sought-after to assess amelanotic and pigmented skin injuries and uses dermatoscopes to differentiate malignant lesions and benign tumors. The instrument has become pivotal in the diagnosis of cancers, such as melanoma. The application of dermatoscopy has become noticeable for the diagnosis of dermatological disorders, such as pigmentary dermatosis, disorders of the hair, scalp and inflammatory dermatosis. Growing awareness about cancer, as well as technological advancements, is expected to foster the adoption of dermatoscopes across North America, Europe and Asia Pacific.
Based on the product, hybrid dermatoscope will grow over 2022-2028 owing to the demand for improved visualization of pigment and vascular structures. The development of novel medical devices is likely to provide lucrative growth opportunities with the ability to examine multiple lesions robustly. Industry participants will continue to invest in hybrid dermatoscope in the diagnosis of pigmented and non-pigmented skin lesions.
In terms of method, hand-handled dermatoscope will account for a notable share of global market due to the need for convenience and improved visualizations. Besides, dermatologists are likely to seek the instrument for tremendous optical image, resolution and easy connectivity to smartphones. These devices are expected to gain traction owing to cost-effective attributes and the upside of offering a better overview of a large scalp area.
With respect to region, North America dermatoscope market outlook will be strong on the back of an increasing prevalence of skin diseases and expansion of healthcare infrastructure. Besides, a surge in fungal infections and scabies across the U.S. and Canada will further the penetration of dermatoscope devices. Robust government policies, along with the expansion of dermatology clinics, will be noticeable across the region.
The competitiveness of global dermatoscope market suggests key industry players could emphasize mergers & acquisitions, product launches, R&D activities, innovations and technological advancements. Some of the key players boosting the competitive landscape are Optilia Instruments AB, AMD Global Telemedicine, Inc., Welch Allyn., 3Gen, Caliber Imaging & Diagnostics, ILLUCO Corporation Ltd., Canfield Scientific, Inc., FotoFinder Systems, Inc., Firefly Global and Heine Optotechnik, among others.
In December 2021, Canfield Scientific announced the acquisition of Medici Medical s.r.l. to roll out Canfield Scientific s.r.l. The company contemplates boosting its dermoscopy portfolio and launching medical dermatology education program.
The COVID-19 pandemic hampered global outlook following the supply chain disruption. In light of the outbreak, postponement or delay of dermoscopy became noticeable globally. Given the rise in infection, digital dermoscopy gained substantial traction across North America and Europe. Moreover, end-users also exhibited a preference for non-contact dermoscopy and video dermatoscope. The post-COVID scenario suggests companies will expand their portfolios amidst soaring cases of infections and skin cancer.
High risk of skin cancer and developments in cancer diagnosis and treatment will foster dermatoscopes market share. Notably, the use of LED technologies will be pronounced to prevent accidental fatalities.
Market, By Product
Market, By Technology
Market, By Method
Market, By Application
Market, By End-use
The above information is provided for the following regions and countries: